Sterling Investment Advisors (Pennsylvania)’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-250
Closed -$37K 179
2022
Q2
$37K Hold
250
0.01% 254
2022
Q1
$43K Hold
250
0.01% 264
2021
Q4
$64K Hold
250
0.02% 229
2021
Q3
$68K Hold
250
0.02% 223
2021
Q2
$56K Hold
250
0.02% 243
2021
Q1
$27K Buy
+250
New +$26.5K 0.01% 298

Other funds holding BNTX

Sterling Investment Advisors (Pennsylvania)'s BNTX Position: Q3 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of BioNTech (BNTX) in Q3 2022, closing a stake of 250 shares — an estimated $37K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in BNTX in Q1 2021 and held it in 6 quarters. The position peaked at $68K in Q3 2021. 264 funds tracked by Wall St. Rank hold BNTX as of Q3 2022.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining BioNTech position as of Q3 2022 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 250 BioNTech shares in Q3 2022, an estimated $37K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in BioNTech in Q1 2021 and held it in 6 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s BioNTech position peaked at $68K in Q3 2021.
  • 264 funds tracked by Wall St. Rank held BioNTech as of Q3 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.